Research output per year
Research output per year
Personal profile
Research interests
Health equity, cancer prevention and control, HPV vaccination, colposcopy, cancer disparities, implementation science, unmet social needs, cancer-related distress, financial toxicity, cost conversations in cancer care, and cancer care delivery.
Clinical interests
Surgical and medical management of gynecologic malignancies, clinical treatment trials, minimally invasive surgery (robotic and laparoscopic), and integrative care
Available to Mentor:
- Undergraduate Students
- Post-Baccalaureate Students
- PhD/MSTP Students
- Postdocs
- Residents and Fellows
Fingerprint
Dive into the research topics where Lindsay Kuroki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ASCCP Committee Opinion: Adjuvant Human Papillomavirus Vaccine for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia
Sharpless, K. E., Marcus, J. Z., Kuroki, L. M., Wiser, A. L. & Flowers, L., Jan 1 2023, In: Journal of lower genital tract disease. 27, 1, p. 93-96 4 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
A case study of adapting a health insurance decision intervention from trial into routine cancer care
Charles, M. E., Kuroki, L. M., Baumann Walker, A. A., Tabak, R. G., James, A., Cooksey, K. & Politi, M. C., Dec 2022, In: BMC Research Notes. 15, 1, 298.Research output: Contribution to journal › Article › peer-review
Open Access -
Challenges and Possible Solutions to Adapting to Virtual Recruitment: Lessons Learned from a Survey Study during the Covid-19 Pandemic
Cooksey, K. E., Mozersky, J., DuBois, J., Kuroki, L., Marx, C. M. & Politi, M. C., Nov 1 2022, In: Ethics and Human Research. 44, 6, p. 23-31 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery
Zamorano, A. S., Mazul, A. L., Marx, C., Mullen, M. M., Greenwade, M., Stewart Massad, L., McCourt, C. K., Hagemann, A. R., Thaker, P. H., Fuh, K. C., Powell, M. A., Mutch, D. G., Khabele, D. & Kuroki, L. M., Dec 2022, In: Gynecologic Oncology Reports. 44, 101075.Research output: Contribution to journal › Article › peer-review
Open Access -
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress
Mullen, M. M., Lomonosova, E., Toboni, M. D., Oplt, A., Cybulla, E., Blachut, B., Zhao, P., Noia, H., Wilke, D., Rankin, E. B., Kuroki, L. M., Hagemann, A. R., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Mutch, D. G., Powell, M. A., Mosammaparast, N., Vindigni, A. & Fuh, K. C., Feb 2022, In: Molecular Cancer Research. 20, 2, p. 265-279 15 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations